<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01264588</url>
  </required_header>
  <id_info>
    <org_study_id>TOPCGP-2008</org_study_id>
    <nct_id>NCT01264588</nct_id>
  </id_info>
  <brief_title>The Effects of Topical Calcium Glycerophosphate on Surgical Wound Healing and Residual Scarring</brief_title>
  <acronym>TOPCGP-2008</acronym>
  <official_title>A Randomized, Single Blind, Comparative, Controlled Study On The Effects Of Topical Calcium Glycerophosphate On Surgical Wound Healing And Residual Scarring In Bilateral Total Knee Arthroplasty Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AkPharma Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Tech University Health Sciences Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cyberderm Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bacharach Institute for Rehabilitation, Pomona, NJ</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AkPharma Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether topical application of calcium
      glycerophosphate will result in superior wound appearance and scar minimization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of surgical wound appearance</measure>
    <time_frame>Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365</time_frame>
    <description>Digital photographs as objective measurements are taken at each time point, and evaluated by an Expert Grader, blinded as to treatment vs. control, for any differences in the time required for wound closure and/ or scar minimization between treated and untreated groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of visible erythema/ inflammation</measure>
    <time_frame>Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365</time_frame>
    <description>Digital photographs as objective measurements are taken at each time point, and evaluated by an Expert Grader, blinded as to treatment vs. control, for any differences in reduction of visible erythema/ inflammation between treated and untreated groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scar minimization or prevention</measure>
    <time_frame>Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365</time_frame>
    <description>Digital photographs as objective measurements are taken at each time point, and evaluated by an Expert Grader, blinded as to treatment vs. control, for any differences in scar appearance between treated and untreated groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incision/ scar pain and sensitivity</measure>
    <time_frame>Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365</time_frame>
    <description>Subjects are asked to rate their pain at the site of incision for each knee, using a scale of 0 (no pain) to 10 (excruciating pain). The pain evaluations are recorded on a pain diary sheet provided at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>Post-Op Day: 3 (baseline), 7, 42, 180, 365</time_frame>
    <description>Range of motion (both flexion and extension) is evaluated using standard goniometric methods.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Wound Healing</condition>
  <condition>Scarring</condition>
  <arm_group>
    <arm_group_label>topical calcium glycerophosphate lotion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard-of-care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Topical calcium glycerophosphate lotion</intervention_name>
    <description>2g once daily for 6 weeks (post-op day 3 thru 42)</description>
    <arm_group_label>topical calcium glycerophosphate lotion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent must be obtained

          -  45-75 years of age

          -  Scheduled for bilateral knee replacement surgery

        Exclusion Criteria:

          -  Employee or immediate family of either AkPharma or employee or immediate family of
             investigator or site personnel

          -  Pregnant or breast feeding Known allergy or hypersensitivity to calcium or phosphorus
             supplements

          -  Diagnosed with type I or type II diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alvin C. Ong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rothman Institute Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rothman Institute Orthopaedics</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2010</study_first_posted>
  <last_update_submitted>December 20, 2010</last_update_submitted>
  <last_update_submitted_qc>December 20, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alvin C. Ong, M.D.</name_title>
    <organization>Rothman Institute Orthopaedics</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

